Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
Cristina Blázquez, Anna Chiarlone, Luigi Bellocchio, et al.
Cell Death and Differentiation (2015) Vol. 22, Iss. 10, pp. 1618-1629
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou, Ujendra Kumar
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 833-833
Open Access | Times Cited: 1108
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 412
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti, Vincenzo Di Marzo, Stefania Petrosino
Progress in Lipid Research (2016) Vol. 62, pp. 107-128
Closed Access | Times Cited: 324
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
Li-Na Gao, Yun Zhang, Keenan Sterling, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 322
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Debra A. Kendall, Guillermo A. Yudowski
Frontiers in Cellular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 304
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
Sandeep Vasant More, Dong‐Kug Choi
Molecular Neurodegeneration (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 133
Microglial Activation in the Pathogenesis of Huntington’s Disease
Huiming Yang, Su Yang, Shanshan Huang, et al.
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 120
CB2 Receptor in Microglia: The Guardian of Self-Control
Joanna Agnieszka Komorowska‐Müller, Anne‐Caroline Schmöle
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 19-19
Open Access | Times Cited: 120
Alterations in synaptic function and plasticity in Huntington disease
Amy Smith-Dijak, Marja D. Sepers, Lynn A. Raymond
Journal of Neurochemistry (2019) Vol. 150, Iss. 4, pp. 346-365
Open Access | Times Cited: 116
Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome
Gerwyn Morris, Michael Berk, Hans Klein, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 6, pp. 4271-4291
Closed Access | Times Cited: 102
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 100
Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation
János Pálóczi, Zoltán V. Varga, George Hasko, et al.
Antioxidants and Redox Signaling (2017) Vol. 29, Iss. 1, pp. 75-108
Open Access | Times Cited: 96
Cortical and Striatal Circuits in Huntington’s Disease
Sonja Blumenstock, Irina Dudanova
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 89
Molecular Pathophysiological Mechanisms in Huntington’s Disease
Anamaria Jurcău
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1432-1432
Open Access | Times Cited: 59
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
Ana Tadijan, Ignacija Vlašić, Josipa Vlainić, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 38
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 485-485
Open Access | Times Cited: 23
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease
Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, et al.
Molecular Pharmacology (2015) Vol. 89, Iss. 3, pp. 364-375
Open Access | Times Cited: 88
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
Javier Díaz-Alonso, Juan Paraíso‐Luna, Carmen Navarrete, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 69
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Ross B. Mounsey, Sarah Mustafa, Lianne Robinson, et al.
Experimental Neurology (2015) Vol. 273, pp. 36-44
Open Access | Times Cited: 68
Cannabinoid receptor ligand bias: implications in the central nervous system
Robert B. Laprairie, Amina M. Bagher, Eileen M. Denovan‐Wright
Current Opinion in Pharmacology (2016) Vol. 32, pp. 32-43
Closed Access | Times Cited: 63
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
Potential of dietary hemp and cannabinoids to modulate immune response to enhance health and performance in animals: opportunities and challenges
Faiz‐ul Hassan, Chunjie Liu, Maryam Mehboob, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Behavioral sensitization to ethanol: Neural basis and factors that influence its acquisition and expression
Rosana Camarini, Ricardo Marcos Pautassi
Brain Research Bulletin (2016) Vol. 125, pp. 53-78
Open Access | Times Cited: 57
Role of microRNAs in Alcohol-Induced Multi-Organ Injury
Sathish Kumar Natarajan, Joseph Pachunka, Justin L. Mott
Biomolecules (2015) Vol. 5, Iss. 4, pp. 3309-3338
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top